July 14, 2026

Setmelanotide in Patients With Acquired Hypothalamic Obesity From Brain Tumors

Setmelanotide significantly reduced body mass index (BMI) and signs of hunger in patients with acquired hypothalamic obesity, according to findings from the phase III TRANSCEND trial published in The ...

The ASCO Post

June 18, 2026

St. Jude Redesignation Marks Collaboration With WHO Toward Improved Pediatric Cancer Outcomes Globally

St. Jude Children's Research Hospital has announced that they have been redesignated as a World Health Organization (WHO) Collaborating Centre for Childhood Cancer.

The ASCO Post

June 17, 2026

New ACSM Expert Consensus Statement: Exercise in Children and Adolescents With Cancer

In children and adolescents undergoing cancer treatment, exercise can be performed safely during and after therapy when appropriately supervised and individualized; further, appropriately prescribed e...

The ASCO Post

June 17, 2026

New ACSM Expert Consensus Statement: Exercise in Children and Adolescents With Cancer

In children and adolescents undergoing cancer treatment, exercise can be performed safely during and after therapy when appropriately supervised and individualized; further, appropriately prescribed e...

The ASCO Post

June 10, 2026

How Cannabis Use May Be Accelerating Breast and Testicular Cancer Rates in AYAs

“The evidence from our study implicates cannabis as a potential etiologic factor contributing to the rising incidence of breast cancer in young females and testis cancer in older adolescent and young ...

The ASCO Post

June 10, 2026

How Cannabis Use May Be Accelerating Breast and Testicular Cancer Rates in AYAs

“The evidence from our study implicates cannabis as a potential etiologic factor contributing to the rising incidence of breast cancer in young females and testis cancer in older adolescent and young ...

The ASCO Post

May 29, 2026

ASCO Collaborates With Ryght AI to Accelerate Site Selection for Metastatic Breast Cancer Trial

ASCO has announced a collaboration with Ryght AI aimed at accelerating the identification and activation of research sites for the CDK4/6 Inhibitor Dosing Knowledge (CDK) Study, a clinical trial evalu...

The ASCO Post

May 29, 2026

ASCO Collaborates With Ryght AI to Accelerate Site Selection for Metastatic Breast Cancer Trial

ASCO has announced a collaboration with Ryght AI aimed at accelerating the identification and activation of research sites for the CDK4/6 Inhibitor Dosing Knowledge (CDK) Study, a clinical trial evalu...

The ASCO Post

May 26, 2026

Guideline-Concordant Care Is Associated With Improved Survival. So, Why Aren’t More AYA Patients Receiving This Care?

Although treatment advances have increased the 5-year relative survival rates across all age groups, including a 15% increase for adolescents and young adults ages 15 to 39 years, it varies widely for...

The ASCO Post

May 26, 2026

Guideline-Concordant Care Is Associated With Improved Survival. So, Why Aren’t More AYA Patients Receiving This Care?

Although treatment advances have increased the 5-year relative survival rates across all age groups, including a 15% increase for adolescents and young adults ages 15 to 39 years, it varies widely for...

The ASCO Post